Y-mAbs Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Welcome, everyone to the 40th Annual JPMorgan Healthcare Conference. My name is Tessa Romero, I'm one of the senior biotech analyst here at JPMorgan, and I'm joined by Taylor Hamley from the team. Our next presenting company is Y-mAbs Therapeutics. And presenting on behalf of the company, we have CEO, Claus Møller. Before I hand it over to Claus, I just wanted to remind all of our listeners to please use the ask-a-question button to submit any questions, and I'm happy to ask on your behalf.
With that, I will turn it over to Claus.
¸- -
Thank you very much, Tessa, and thank you, everybody, for listening in today. It's my pleasure to give the Y-mAbs company presentation here in January 2022 at the JPMorgan conference. Unfortunately, it's virtual and not for real, but I hope we will be seeing each other, everybody in January next year.
With this disclaimer, I think
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |